2002
DOI: 10.1016/s0264-410x(02)00512-1
|View full text |Cite
|
Sign up to set email alerts
|

Inflexal®V a trivalent virosome subunit influenza vaccine: production

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
67
0

Year Published

2003
2003
2021
2021

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 162 publications
(67 citation statements)
references
References 12 publications
0
67
0
Order By: Relevance
“…Virosomes differ from VLPs as they are composed of both viral proteins and lipids, either viral or otherwise, and resemble liposomes [176]. Immunopotentiating reconstituted influenza virosomes (IRIVs) include influenza membrane proteins hemagglutinin and neuraminidase in the construct [177] and in addition to their application for influenza vaccines [178,179] have been shown to be efficacious delivery vehicles for vaccines against hepatitis A [180] and HIV [181].…”
Section: Virus-like Particlesmentioning
confidence: 99%
“…Virosomes differ from VLPs as they are composed of both viral proteins and lipids, either viral or otherwise, and resemble liposomes [176]. Immunopotentiating reconstituted influenza virosomes (IRIVs) include influenza membrane proteins hemagglutinin and neuraminidase in the construct [177] and in addition to their application for influenza vaccines [178,179] have been shown to be efficacious delivery vehicles for vaccines against hepatitis A [180] and HIV [181].…”
Section: Virus-like Particlesmentioning
confidence: 99%
“…79 Virosome adjuvant system consists of an influenza virus envelope devoid of inner core and genetic information, with the influenza virus surface antigens neuraminidase and hemagglutinin integrated into phosphatidylcholine bilayer liposomes. 80 Virosomal influenza vaccines demonstrated to induce antibody titers comparable to the not-adjuvanted, IM, split/subunit vaccines, against vaccine homologous strains. Only one study evaluated the performances of virosomal influenza vaccine against circulating viruses that did not have a good match with vaccine strains, due to antigenic drift.…”
Section: Tm -Adjuvanted Vaccinesmentioning
confidence: 99%
“…It has been shown that such vaccines are highly immunogenic and well tolerated in children, young adults, and among the elderly. 2 The two vaccines (subunit and attenuated) were similarly efficacious in preventing culturepositive influenza illness. 3 Some safety concerns related to influenza vaccination include the eliciting of immune responses not induced by natural infection, that may lead to autoimmunity.…”
Section: Background-available Influenza Vaccines Limitations and Thementioning
confidence: 99%